𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Uses of vaccinia virus as a vector for the production of live recombinant vaccines

✍ Scribed by Geoffrey L. Smith; Bernard Moss

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
685 KB
Volume
1
Category
Article
ISSN
0265-9247

No coin nor oath required. For personal study only.

✦ Synopsis

Influence of ethanol on chromosome segregation during the first and second meiotic divisions in the mouse egg. J. exp. Zool. 230, 3 15-320. 18 KAUFMAN, M. H. & BAIN, I. M. (19846). The development potential of ethanol-induced monosomic and trisomic conceptuses in the mouse. J. exp. Zool. (In the Press.) 19 O'SHEA, K. S. & KAUFMAN, M. H. (1 980). Neural tube closure defects following in vitro exposure of mouse embryos to xylocaine.

📜 SIMILAR VOLUMES

From virus to vaccine: Recombinant mamma
From virus to vaccine: Recombinant mammalian cell lines as substrates for the production of herpes simplex virus vaccines
✍ Laurence A. Lasky 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

## Abstract The use of mammalian cells as substrates for the production of various vaccines is a time‐honored procedure. With the advent of recombinant DNA technology, various investigators soon realized that these techniques could be applied to mammalian cells to convert them to reliable, safe pro

Cross-species transfer of viruses: impli
Cross-species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live-virus vaccines
✍ Derrick Louz; Hans E. Bergmans; Birgit P. Loos; Rob C. Hoeben 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

All living organisms are continuously exposed to a plethora of viruses. In general, viruses tend to be restricted to the natural host species which they infect. From time to time viruses cross the host-range barrier expanding their host range. However, in very rare cases cross-species transfer is fo

A placebo-controlled dose response study
A placebo-controlled dose response study of the reactogenicity and immunogenicity of a live cold-recombinant influenza B virus vaccine in healthy volunteers
✍ Dr. U. Ganzinger; H. Bachmayer; E. Liehl; J. J. Martindale; F. Hamilton; Dr. E. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

A live cold-recombinant influenza B virus vaccine (RB77) was given intranasally in a placebo-controlled, double blind study to volunteers in dosages of 10(7.9) EID50/ml, 10(7.25) EID50/ml, 10(5.7) EID50/ml. The tolerability, safety, and immunogenicity of the vaccine were investigated. No revertant v

Evaluation of a virus derived from MDCK
Evaluation of a virus derived from MDCK cells infected persistently with influenza A virus as a potential live-attenuated vaccine candidate in the mouse model
✍ Beixing Liu; Md. Jaber Hossain; Isamu Mori; Yoshinobu Kimura 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

## Abstract A temperature‐sensitive mutant virus unable to replicate at 38°C was recovered from passage 189 (IVpi‐189) of Madin‐Darby canine kidney cells infected persistently with influenza A. Immunofluorescent staining of the IVpi‐189 virus‐infected cells revealed disrupted transport of the matri

Harvesting and concentration of human in
Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines
✍ Bernd Kalbfuss; Yvonne Genzel; Michael Wolff; Anke Zimmermann; Robert Morenweise 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 2 views

## Abstract A process scheme for the harvesting and concentration of cell culture‐derived human influenza A virus is presented. The scheme comprises two static filtration steps, chemical inactivation by β‐propiolactone and cross‐flow ultrafiltration. Human influenza A virus A/PR/8/34 (H1N1) was pro